CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

The jab is also known as Godzilla or Triple G, and authorities have warned that social media has become a “wild west” for ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

Survey shows high death rates among children with Type 1 diabetes in India due to limited insulin access and late diagnosis.

Aher holds an insulin pen next to his father, Lual, in their home in Ariath, Aweil North, South Sudan. 2025 © Isaac Buay ...

As per SNS Insider Research, North America Leads the Market with 42% Market Share, While Asia Pacific Emerges as the Fastest Growing Region with Strong Adoption of Connected Diabetes ...

Health officials have repeatedly warned Britons against buying the jabs on social media and to be aware of scam online ...

“Faster-acting drugs have a higher abuse potential,” said DiFeliceantonio. “They have a different impact on the brain. So if ...

According to DataM Intelligence, the U.S. Software as a Medical Device (SaMD) Market Size reached USD 205.12 million in 2024 ...